Literature DB >> 10714661

Progressive necrotic myelopathy: clinical course in 9 patients.

J D Katz1, A H Ropper.   

Abstract

OBJECTIVE: To review the clinical, laboratory, and radiological findings of 9 patients who had progressive idiopathic myelopathy with evidence of spinal cord necrosis. DESIGN AND METHODS: We reviewed personally examined cases of myelopathy that fulfilled the following criteria: (1) regional loss of reflexes, flaccidity, and muscle atrophy; (2) magnetic resonance imaging showing a shrunken or cavitated cord without evidence of arteriovenous malformation; (3) electromyogram showing denervation over several contiguous spinal cord sgements with preservation of sensory potentials in some cases; and (4) the absence of evidence of systemic disease or neoplasm.
RESULTS: The illness began in these patients after the age of 40 years, with prominent burning or tingling limb pain, occasionally with radicular features or with less well-defined back, neck, or abdominal pain. Leg or infrequently arm weakness appeared concurrently or soon after the onset of pain. The most distinctive feature was a saltatory progression of symptoms, punctuated by both acute and subacute worsenings approximately every 3 to 9 months, culminating in paraplegia or tetraplegia. The distinguishing clinical findings, together indicative of destruction of gray matter elements of the cord, were limb atrophy, persistent areflexia, and flaccidity. The concentration of cerebrospinal fluid protein was typically elevated between 500 g/L and 1000 g/L, without oligoclonal bands, accompanied infrequently by pleocytosis. Magnetic resonance imaging showed features suggesting cord necrosis, specifically swelling, T2-weighted hyperintensity, and gadolinium enhancement over several spinal cord segments, succeeded months later by atrophy in the same regions. Necrosis of the cord was found in biopsy material from one patient and postmortem pathology in another case, but inflammation and blood vessel abnormalities were absent. Only 2 patients had prolonged visual evoked responses. The disease progressed despite immune-modulating treatments although several patients had brief epochs of limited improvement.
CONCLUSIONS: The saltatory course, prolonged visual evoked responses in 2 patients, and a cranial abnormality on magnetic resonance imaging in another, raised the possibility of a link to multiple sclerosis. However, the normal cranial magnetic resonance imaging scans in 6 other patients, uniformly absent oligoclonal bands, and poor response to treatment were atypical for multiple sclerosis. On the basis of shared clinical and laboratory features, idiopathic progressive necrotic myelopathy is indistinguishable from a limited form of Devic disease.

Entities:  

Mesh:

Year:  2000        PMID: 10714661     DOI: 10.1001/archneur.57.3.355

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?

Authors:  Viviana Nociti; Anna Paola Batocchi; Marco Luigetti; Amelia Conte; Vita Santa Lorusso; Silvia Roiati; Tommaso Tartaglione; Alessandra Del Grande; Mario Sabatelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

2.  Clinico-radiological correlation in a cohort of cervical myelopathy patients.

Authors:  Praveen S Kumar; R Y Kalpana
Journal:  J Clin Diagn Res       Date:  2015-01-01

3.  Acute Ascending Necrotizing Myelitis After COVID-19 Infection: A Clinicopathologic Report.

Authors:  Luis Guada; Franklyn Rocha Cabrero; Nicole L Baldwin; Allan D Levi; Sakir H Gultekin; Ashok Verma
Journal:  Neurol Clin Pract       Date:  2022-06

4.  Unexpected prion phenotypes in experimentally transfused animals: predictive models for humans?

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Prion       Date:  2018-08-16       Impact factor: 3.931

Review 5.  Paraneoplastic neurological syndromes.

Authors:  F Leypoldt; K-P Wandinger
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 6.  Demyelinating disorders: update on transverse myelitis.

Authors:  Chitra Krishnan; Adam I Kaplin; Carlos A Pardo; Douglas A Kerr; Sanjay C Keswani
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 6.030

7.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

8.  Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Nina Jaffré; Vincent Lebon; Etienne Levavasseur; Nathalie Streichenberger; Chryslain Sumian; Armand Perret-Liaudet; Marc Eloit; Olivier Andreoletti; Stéphane Haïk; Philippe Hantraye; Jean-Philippe Deslys
Journal:  Nat Commun       Date:  2017-11-02       Impact factor: 14.919

9.  COVID-19-associated acute necrotizing myelitis.

Authors:  Javier Sotoca; Yensa Rodríguez-Álvarez
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-06-10

Review 10.  Autoimmune Neurological Conditions Associated With Zika Virus Infection.

Authors:  Yeny Acosta-Ampudia; Diana M Monsalve; Luis F Castillo-Medina; Yhojan Rodríguez; Yovana Pacheco; Susan Halstead; Hugh J Willison; Juan-Manuel Anaya; Carolina Ramírez-Santana
Journal:  Front Mol Neurosci       Date:  2018-04-11       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.